People with mild cognitive impairment considering dementia care research in 2026 should ask how their electronic health records will be used, what participation demands, and how consent works. Mild cognitive impairment means memory or thinking changes others notice, but daily tasks remain manageable, and electronic health records are the routine notes, diagnoses, prescriptions, and visits your clinics already keep.
Researchers now use those records to study risk and invite volunteers. Columbia Mailman School of Public Health reports its M3AD platform harmonizes records from nearly 10 million patients, including about 60,000 with Alzheimer's and related dementias, in its new data platform description. That work makes your questions about selection, burden, and privacy more practical.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- How do researchers use health records to find risk?
- What will the study ask you to do?
- Which questions should you ask before you agree?
- How does consent work when thinking is affected?
How do researchers use health records to find risk?
Clinics can run screening software over routine record data to flag higher risk. Healio reporting on AAIC 2026 says the eRADAR tool uses about 30 routine variables to flag primary-care patients age 65 and older without known dementia as high risk for undiagnosed impairment in its AAIC 2026 conference coverage. A flag is not a diagnosis.
It starts outreach for a memory check. Accuracy depends on what record parts the model reads. Diagnoses, drugs, visit notes, and use patterns each add different signals. Ask whether the study uses notes, codes only, or both, and how it checks a flag before contacting you.
What will the study ask you to do?
Most Alzheimer's trials require a study partner who knows you well, often a spouse, adult child, or close friend, according to the National Institute on Aging in its guidance on participating in dementia research. The partner reports changes, helps with visits, and supports decisions. Confirm who can serve, whether the partner must attend each visit, and what happens if that person becomes unavailable.
Expect a screening exam, follow-up visits, and record review. Preliminary results shared by the NIA-funded eRADAR team found only 29% of high-risk Kaiser Permanente Washington patients and 31% at UCSF clinics completed the outreach assessment visit, as described in the trial team's preliminary report. Ask about location, length, travel, makeup visits, and withdrawal rules.
Which questions should you ask before you agree?
The National Institute on Aging advises prospective volunteers to ask the team what the study seeks to learn, its risks, side effects, benefits, time demands, visit schedule, and pay or reimbursement. Bring this list and write down the answers: Ask who sees your data and for how long.
Ask whether participation affects your regular care. Ask when and how you will learn overall findings.
- What question does this study answer, and why was I flagged?
- What are the risks, side effects, and possible benefits for me?
- How many visits, how long, where, and can I leave at any time?
- Do my partner and I receive pay, travel funds, or test results?
- Which parts of my health record will you use, store, and share?
How does consent work when thinking is affected?
Mild impairment can affect understanding of risks and choices. Teams should assess your capacity to consent in plain language, at a good time of day, with your partner present if you wish. If you lack capacity for a specific study, a legally authorized representative may consent for you under federal research protections.
Clarify your rights before signing. Ask how the team checks understanding, whether you can appoint a representative in advance, and how dissent is handled. Keep a copy of the consent form, contact names, and the process for questions, complaints, or withdrawal.
You Might Also Like
- UAS-CLEAR Dementia Care Research Data Priorities in 2026: A Source-Checked Research Briefing for People With Mild Cognitive Impairment
- NHATS and NSOC Dementia Care Data Priorities in 2026: A Source-Checked Research Briefing for People With Mild Cognitive Impairment
- LiBBY Trial Findings for Late-Stage Dementia Agitation in 2026: A Source-Checked Research Briefing for People With Mild Cognitive Impairment
